Abivax
Carol Brosgart is a Clinical Professor of Medicine, Epidemiology and Biostatistics at the University of California; Senior Advisor on Science and Policy, VHAC at the CDC Foundation and the Division of Viral Hepatitis at CDC; Former VP Clinical Research of Gilead Sciences.
This person is not in the org chart
This person is not in any offices
Abivax
Abivax SA is a clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer.